Investigating the mechanism of hyperglycemia-induced fetal cardiac hypertrophy

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Han, Sha Sha ^a   Wang, Guang ^b   Jin, Ya ^a   Ma, Zheng Lai ^b   Jia, Wei Jing ^a   Wu, Xia ^a   Wang, Xiao Yu ^b   He, Mei Yao ^a   Cheng, Xin ^b   Li, Wei Jing ^a   Yang, Xuesong ^b   Liu, Guo Sheng ^a  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 10; CONNEXIN 43; GLUCOSE; MYOSIN HEAVY CHAIN BETA; POTASSIUM CHANNEL KCNE1; STREPTOZOCIN; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; HOMEOBOX PROTEIN NKX-2.5; HOMEODOMAIN PROTEIN; NKX2-5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SIZE; COLOR ULTRASOUND FLOWMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FETUS; FETUS DISEASE; FETUS HEART; GENE TARGETING; H9C2 CELL LINE; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; M MODE ECHOCARDIOGRAPHY; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL LINE; CYTOLOGY; DIABETES MELLITUS; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CARDIOMEGALY; CELL LINE; CELL PROLIFERATION; CELL SIZE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; FETAL HEART; HOMEOBOX PROTEIN NKX-2.5; HOMEODOMAIN PROTEINS; HUMANS; HYPERGLYCEMIA; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TRANSCRIPTION FACTORS;

EID: 84947976486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139141     Document Type: Article

References (37)

1. Ejdesjo A, Wentzel P, Eriksson UJ. Influence of maternal metabolism and parental genetics on fetal maldevelopment in diabetic rat pregnancy. Am J Physiol-Endoc M. 2012; 302(10):E1198-209. doi: 10.1152/ajpendo.00661.2011 PMID: 22374754.
2. Gheorman L, Iliescu D, Ceausu I, Paulescu D, Plesea IE, Gheorman V. Importance of early complex evaluation in high-risk pregnancy associated to diabetes mellitus. Case presentation and review of the literature. Rom J Morphol Embryo. 2011; 52(3 Suppl):1127-32. PMID: 22119836.
3. Simeone RM, Devine OJ, Marcinkevage JA, Gilboa SM, Razzaghi H, Bardenheier BH, et al. Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. Am J Prev Med. 2015; 48(2):195-204. doi: 10.1016/j.amepre.2014.09.002 PMID: 25326416.
4. Li X, Weng H, Xu C, Reece EA, Yang P. Oxidative stress-induced JNK1/2 activation triggers proapoptotic signaling and apoptosis that leads to diabetic embryopathy. Diabetes. 2012; 61(8):2084-92. doi: 10.2337/db11-1624 PMID: 22688338.
5. Zangen SW, Yaffe P, Shechtman S, Zangen DH, Ornoy A. The role of reactive oxygen species in diabetes-induced anomalies in embryos of Cohen diabetic rats. Int J Exp Diabetes Res. 2002; 3(4):247-55. doi: 10.1080/15604280214933 PMID: 12546278.
6. Jin YM, Zhao SZ, Zhang ZL, Chen Y, Cheng X, Chuai M, et al. High glucose level induces cardiovascular dysplasia during early embryo development. Exp Clin Endocr Diab. 2013; 121(8):448-54. doi: 10.1055/s-0033-1349080 PMID: 23864493.
7. Corrigan N, Brazil DP, McAuliffe F. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol. 2009; 85(6):523-30. doi: 10.1002/bdra.20567 PMID: 19180650.
8. Ding F, Yu L, Wang M, Xu S, Xia Q, Fu G. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2. Amino Acids. 2013; 45(2):339-49. doi: 10.1007/s00726-013-1504-2 PMID: 23665912.
9. Huynh K, Kiriazis H, Du XJ, Love JE, Jandeleit-Dahm KA, Forbes JM, et al. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in thedb/db mouse model of type 2 diabetes. Diabetologia. 2012; 55(5):1544-53. doi: 10.1007/s00125-012-2495-3 PMID: 22374176.
10. Martinsen BJ. Reference guide to the stages of chick heart embryology. Developmental Dynamics. 2005; 233(4):1217-37. doi: 10.1002/Dvdy.20468 PMID: 15986452.
11. Zaffran S, Kelly RG, Meilhac SM, Buckingham ME, Brown NA. Right ventricular myocardium derives from the anterior heart field. Circ Res. 2004; 95(3):261-8. doi: 10.1161/01.RES.0000136815.73623.BE PMID: 15217909.
12. Beiman M, Shilo BZ, Volk T. Heartless, aDrosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages. Genes Dev. 1996; 10(23):2993-3002.doi: 10.1101/gad.10.23.2993 PMID: 8957000.
13. Yang X, Dormann D, Munsterberg AE, Weijer CJ. Cell movement patterns during gastrulation in the chick are controlled by positive and negative chemotaxis mediated by FGF4 and FGF8. Dev Cell. 2002; 3(3):425-37. doi: 10.1016/S1534-5807(02)00256-3 PMID: 12361604.
14. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol. 2003; 258(1):1-19. doi: 10.1016/S0012-1606(03)00112-X PMID: 12781678.
15. Kumar SD, Dheen ST, Tay SSW. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol. 2007; 6:34. doi: 10.1186/1475-2840-6-34 PMID: 17967198.
16. Kumar SD, Vijaya M, Samy RP, Dheen ST, Ren M, Watt F, et al. Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice. Free Radical Bio Med. 2012; 53(8):1595-606. doi: 10.1016/j.freeradbiomed.2012.07.008 PMID: 22819979.
17. Li Y, Wang XY, Zhang ZL, Cheng X, Li XD, Chuai ML, et al. Excess ROS induced byAAPH causes myocardial hypertrophy in the developing chick embryo. Int J Cardiol. 2014; 176(1):62-73. doi: 10.1016/j.ijcard.2014.06.044 PMID: 25037699.
18. Qin RJ. The Ultrasonic cardiogram measurement of 909 normal full-term infants and children. Zhonghua Er KeZaZhi (chinese). 1981; 19(2):92-5.
19. Xu JJ, Li HB, Irwin MG, Xia ZY, Mao XW, Lei SQ, et al. Propofol Ameliorates Hyperglycemia-Induced Cardiac Hypertrophy and Dysfunction via Heme Oxygenase-1/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Rats. Crit Care Med. 2014; 42(8):E583-E94. doi: 10.1097/Ccm.0000000000000415 PMID: 24810525.
20. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development. 1999; 126(6):1269-80. PMID: 10021345.
21. Zhang L, Nomura-Kitabayashi A, Sultana N, Cai WB, Cai XQ, Moon AM, et al. Mesodermal Nkx2.5 is necessary and sufficient for early second heart field development. Dev Biol. 2014; 390(1):68-79. doi: 10.1016/j.ydbio.2014.02.023 PMID: 24613616.
22. Maron BJ. Hypertrophic cardiomyopathy: An important global disease. Am J Med. 2004; 116(1):63-5. doi: 10.1016/j.amjmed.2003.10.012 PMID: 14706671.
23. Maron BJ. Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Circulation. 2010; 121(3):445-56. doi: 10.1161/Circulationaha.109.878579 PMID: 20100987.
24. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics. J Cardiovasc Electr. 2008; 19(1):104-10. doi: 10.1111/j.1540-8167.2007.00965.x PMID: 17916152.
25. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl J Med. 1990; 322(22):1561-6. doi: 10.1056/NEJM199005313222203 PMID: 2139921.
26. Corrigan N, Treacy A, Brazil DP, McAuliffe FM. Cardiomyopathy and diastolic dysfunction in the embryo and neonate of a type 1 diabetic mouse model. Reprod Sci. 2013; 20(7):781-90. doi: 10.1177/1933719112466298 PMID: 23269095.
27. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart. 2007; 93(8):903-7. doi: 10.1136/hrt.2005.068270 PMID: 16670100.
28. Aman J, Hansson U, Ostlund I, Wall K, Persson B. Increased fat mass and cardiac septal hypertrophy in newborn infants of mothers with well-controlled diabetes during pregnancy. Neonatology. 2011; 100(2):147-54. doi: 10.1159/000323741 PMID: 21430391.
29. Morkin E, Kimata S, Skillman JJ. Myosin synthesis and degradation during development of cardiac hypertrophy in the rabbit. Circ Res. 1972; 30(6):690-702. PMID: 4260249.
30. Jaiswal A, Kumar S, Seth S, Dinda AK, Maulik SK. Effect of U50,488H, a kappa-opioid receptor agonist on myocardial alpha-and beta-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem. 2010; 345(1-2):231-40. doi: 10.1007/s11010-010-0577-4 PMID: 20730476.
31. Huang J, Elicker J, Bowens N, Liu X, Cheng L, Cappola TP, et al. Myocardin regulates BMP10 expression and is required for heart development. J Clin Invest. 2012; 122(10):3678-91. doi: 10.1172/JCI63635 PMID: 22996691.
32. Pashmforoush M, Lu JT, Chen HY, St Amand T, Kondo R, Pradervand S, et al. Nkx2-5 pathways and congenital heart disease: Loss of ventricular myocyte lineage progressive cardiomyopathy and complete heart block. Cell. 2004; 117(3):373-86. doi: 10.1016/S0092-8674(04)00405-2 PMID: 15109497.
33. Azakie A, Fineman JR, He YP. Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo. J Thorac Cardiov Sur. 2006; 132(6):1262-U6. doi: 10.1016/j.jtcvs.2006.08. 005 PMID: 17140938.
34. Terada R, Warren S, Lu JT, Chien KR, Wessels A, Kasahara H. Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation. Cardiovasc Res. 2011; 91(2):289-99. doi: 10.1093/cvr/cvr037 PMID: 21285290.
35. Munshi NV. Gene Regulatory Networks in Cardiac Conduction System Development. Circ Res. 2012; 110(11):1525-37. doi: 10.1161/Circresaha.111.260026 PMID: 22628576.
36. Akazawa H, Komuro I. Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases. Pharmacol therapeut. 2005; 107(2):252-68. doi: 10.1016/j.pharmthera.2005.03.005 PMID: 15925411.
37. Kobylinska J, Dworzanski W, Cendrowska-Pinkosz M, Dworzanska A, Hermanowicz-Dryka T, Kiszka J, et al. Morphological and molecular bases of cardiac development. Postep Hig Med Dosw 2013; 67:950-7. doi: 10.5604/17322693.1066060 PMID: 24088538.